The abstract is read at the publisher; the summary is JClub's.
Integrated upstream–downstream bioprocess engineering is limited by “subsystems optimization,” and four systems leverage points are identified to improve consolidation despite persistent misalignment with commercially relevant metrics.
- Why it matters: Bioprocessing has lagged behind chemical manufacturing in adopting comprehensive systems engineering, leaving overall performance constrained when subsystems are optimized separately.
- What they did: This review analyzes strategies for integrated bioprocess development and highlights four leverage points: product accessibility to reduce cell lysis, strain changes to remove contaminants, product adaptation for simpler purification, and improved strain tolerance to aid separation.
- The result: Integrative approaches substantially improve process consolidation, but academic work still fails commercially relevant metrics, implying a need for a more holistic systems perspective to achieve transformative impact.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.